T
Tarik M. Elsheikh
Researcher at Ball Memorial Hospital
Publications - 34
Citations - 1039
Tarik M. Elsheikh is an academic researcher from Ball Memorial Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 27 publications receiving 992 citations.
Papers
More filters
Journal ArticleDOI
Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma.
Tarik M. Elsheikh,Sylvia L. Asa,John K.C. Chan,Ronald A. DeLellis,Clara S. Heffess,Virginia A. LiVolsi,Bruce M. Wenig +6 more
TL;DR: Histologic features considered most helpful in diagnosing FVPC were nuclear clearing, nuclear grooves, nuclear overlapping and crowding, nuclear membrane irregularity, and nuclear enlargement.
Journal ArticleDOI
Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature
TL;DR: Following follow-up surgical excision of CNB yielding ALH or LCIS is warranted in all patients with CNB diagnoses of LCIS or ALH, to exclude the presence of cancer.
Journal ArticleDOI
Pediatric Thyroid Nodules: Disease Demographics and Clinical Management as Determined by Fine Needle Aspiration Biopsy
TL;DR: FNAB is useful in the management of pediatric thyroid nodules because of its high diagnostic accuracy and minimal invasiveness, and the prevalence of malignancy in pediatric patients with thyroid nodule was 18%.
Journal ArticleDOI
Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting : the Papanicolaou Society of Cytopathology Practice Guidelines Task Force.
Journal ArticleDOI
The significance of “low‐grade squamous intraepithelial lesion, cannot exclude high‐grade squamous intraepithelial lesion” as a distinct squamous abnormality category in Papanicolaou tests
TL;DR: The term atypical squamous cells (ASC), cannot exclude HSIL (ASC‐H) was introduced in 2001 in the Bethesda System to define changes suggestive, but not diagnostic, of HSIL in the absence of unequivocal squamous intraepithelial lesion (SIL).